Literature DB >> 29864957

RETRACTED: TUG1 alleviates hypoxia injury by targeting miR-124 in H9c2 cells.

Nianxin Jiang1, Jingwen Xia2, Bing Jiang1, Yinghui Xu1, Yansong Li3.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Given the comments of Dr Elisabeth Bik regarding this article “This paper belongs to a set of over 400 papers (as per February 2020) that share very similar Western blots with tadpole-like shaped bands, the same background pattern, and striking similarities in title structures, paper layout, bar graph design, and - in a subset - flow cytometry panels”, the journal requested the authors to provide the raw data. However, the authors were not able to fulfil this request and therefore the Editor-in-Chief decided to retract the article.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Hypoxia; Myocardial infarction; Sp1/survivin signaling pathway; TUG1; miR-124

Mesh:

Substances:

Year:  2018        PMID: 29864957     DOI: 10.1016/j.biopha.2018.04.191

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  13 in total

1.  LncRNA TUG1 contributes to cardiac hypertrophy via regulating miR-29b-3p.

Authors:  Xue Zou; Jialiang Wang; Li Tang; Qian Wen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-06-10       Impact factor: 2.416

2.  Inhibition of long non-coding RNA TUG1 protects against diabetic cardiomyopathy induced diastolic dysfunction by regulating miR-499-5p.

Authors:  Lei Zhao; Weiguo Li; Hao Zhao
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

3.  LncRNA ANRIL knockdown relieves myocardial cell apoptosis in acute myocardial infarction by regulating IL-33/ST2.

Authors:  Jinhua Yang; Xianwei Huang; Fudong Hu; Xin Fu; Zhengming Jiang; Kui Chen
Journal:  Cell Cycle       Date:  2019-11-01       Impact factor: 4.534

4.  Development of a Bioinformatics Framework for Identification and Validation of Genomic Biomarkers and Key Immunopathology Processes and Controllers in Infectious and Non-infectious Severe Inflammatory Response Syndrome.

Authors:  Dong Ling Tong; Karen E Kempsell; Tamas Szakmany; Graham Ball
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

5.  miR-22 Host Gene Enhances Nuclear Factor-kappa B Activation to Aggravate Hypoxia-induced Injury in AC16 Cardiomyocytes.

Authors:  Xu Yan; Jinlan Hou
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

6.  SCD leads to the development and progression of acute myocardial infarction through the AMPK signaling pathway.

Authors:  Lijie Wang; Fengxia Yu
Journal:  BMC Cardiovasc Disord       Date:  2021-04-20       Impact factor: 2.298

7.  Inhibition of lncRNA NEAT1 protects endothelial cells against hypoxia/reoxygenation‑induced NLRP3 inflammasome activation by targeting the miR‑204/BRCC3 axis.

Authors:  Tao Yao; Yiting Song; Shutao Li; Jing Gu; Xuetao Yan
Journal:  Mol Med Rep       Date:  2021-12-01       Impact factor: 2.952

Review 8.  Long non-coding RNAs and microRNAs as crucial regulators in cardio-oncology.

Authors:  Sarath Babu Nukala; Jordan Jousma; Yoonje Cho; Won Hee Lee; Sang-Ging Ong
Journal:  Cell Biosci       Date:  2022-03-04       Impact factor: 7.133

9.  MicroRNA-133b Alleviates Hypoxia Injury by Direct Targeting on NOD-Like Receptor Protein 3 in Rat H9c2 Cardiomyocyte.

Authors:  Yongmei Zhou; Hui Huang; Xiaolin Hou
Journal:  Cardiol Res Pract       Date:  2019-11-12       Impact factor: 1.866

Review 10.  The role of hydrogen peroxide-inducible clone-5 in tumor progression.

Authors:  Wen-Sheng Wu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.